Skip to main content
Skip to "About government"
Language selection
WxT Language switcher
Français
fr
You are here
Canada.ca
Health
Recalls and safety alerts
Recalls and safety alerts
Search
Search
Include archived
Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Issue: Health products
Remove filter for
Last updated: January 2022
Remove filter for
Last updated: 2022
Remove filter for
Type: Public advisory
Clear all
Search filters
Type
Alert
1
results available
(-) Public advisory
Audience
(-) Healthcare
Category
Health products
1
results available
Issue
(-) Health products
Product safety
1
results available
Last updated
(-) January 2022
(-) 2022
Recall class
Displaying 1 - 1 of 1 items.
Health Canada safety review finds link between the use of Xeljanz and Xeljanz XR (tofacitinib) and increased risk of serious heart-related issues and cancer
Alert
Public advisory | 2022-01-12